BIOTALYS NV (BTLS.BR) Stock Price & Overview

EBR:BTLS • BE0974386188

Current stock price

2.305 EUR
+0.08 (+3.36%)
Last:

The current stock price of BTLS.BR is 2.305 EUR. Today BTLS.BR is up by 3.36%. In the past month the price increased by 5.19%. In the past year, price decreased by -28.53%.

BTLS.BR Key Statistics

52-Week Range1.56 - 5.5
Current BTLS.BR stock price positioned within its 52-week range.
1-Month Range1.56 - 3.05
Current BTLS.BR stock price positioned within its 1-month range.
Market Cap
86.599M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.41
Dividend Yield
N/A

BTLS.BR Stock Performance

Today
+3.36%
1 Week
+2.29%
1 Month
+5.19%
3 Months
-39.07%
Longer-term
6 Months -49.43%
1 Year -28.53%
2 Years -28.06%
3 Years -65.69%
5 Years N/A
10 Years N/A

BTLS.BR Stock Chart

BIOTALYS NV / BTLS Daily stock chart

BTLS.BR Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to BTLS.BR. When comparing the yearly performance of all stocks, BTLS.BR is a bad performer in the overall market: 96.1% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BTLS.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BTLS.BR. While BTLS.BR seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BTLS.BR Earnings

Next Earnings DateN/A
Last Earnings DateMar 27, 2026
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

BTLS.BR Forecast & Estimates

9 analysts have analysed BTLS.BR and the average price target is 6.12 EUR. This implies a price increase of 165.51% is expected in the next year compared to the current price of 2.305.

For the next year, analysts expect an EPS growth of -0.88% and a revenue growth -52% for BTLS.BR


Analysts
Analysts84.44
Price Target6.12 (165.51%)
EPS Next Y-0.88%
Revenue Next Year-52%

BTLS.BR Groups

Sector & Classification

Index Membership

BTLS.BR Financial Highlights

Over the last trailing twelve months BTLS.BR reported a non-GAAP Earnings per Share(EPS) of -0.41. The EPS increased by 19.48% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-14.83M
Industry RankSector Rank
PM (TTM) N/A
ROA -51.18%
ROE -74.88%
Debt/Equity 0.16
Chartmill High Growth Momentum
EPS Q2Q%-7.58%
Sales Q2Q%N/A
EPS 1Y (TTM)19.48%
Revenue 1Y (TTM)N/A

BTLS.BR Ownership

Ownership
Inst Owners21.37%
Shares37.57M
Float19.64M
Ins Owners4.83%
Short Float %N/A
Short RatioN/A

About BTLS.BR

Company Profile

BTLS logo image Biotalys NV engages in the development of sustainable crop protection products. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 63 full-time employees. The company went IPO on 2021-07-02. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. The company develops technology for sustainable crop protection. The company offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. The company also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.

Company Info

IPO: 2021-07-02

BIOTALYS NV

Buchtenstraat 11

Ghent OOST-VLAANDEREN BE

Employees: 63

BTLS Company Website

BTLS Investor Relations

Phone: 3292745400

BIOTALYS NV / BTLS.BR FAQ

What does BIOTALYS NV do?

Biotalys NV engages in the development of sustainable crop protection products. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 63 full-time employees. The company went IPO on 2021-07-02. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. The company develops technology for sustainable crop protection. The company offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. The company also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.


What is the stock price of BIOTALYS NV today?

The current stock price of BTLS.BR is 2.305 EUR. The price increased by 3.36% in the last trading session.


Does BTLS stock pay dividends?

BTLS.BR does not pay a dividend.


What is the ChartMill technical and fundamental rating of BTLS stock?

BTLS.BR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What sector and industry does BIOTALYS NV belong to?

BIOTALYS NV (BTLS.BR) operates in the Materials sector and the Chemicals industry.


Can you provide the growth outlook for BIOTALYS NV?

The Revenue of BIOTALYS NV (BTLS.BR) is expected to decline by -52% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.